The effects of mecillinam, trimethoprim and ciprofloxacin, antibiotics used in the treatment of urinary tract infections, on the aquatic environment were assessed. Mecillinam and ciprofloxacin were both readily biodegradable (primary degradation) in activated sludge, whereas trimethoprim persisted. The toxicity of these antibiotics towards sludge bacteria, a green alga, a cyanobacterium, a crustacean and a fish were investigated; both mecillinam and ciprofloxacin were highly toxic to the cyanobacterium Microcystis aeruginosa (EC(50) in the range 5-60 Ìg/L). Risk characterization for the aquatic environment was performed for the three compounds by calculating the predicted environmental concentration (PEC) and the predicted no-effects concentration (PNEC). A PEC/PNEC ratio of <1 indicates that, with the present pattern of use, no environmental risk is expected. PEC/PNEC ratios of <1 for present usage in Europe were found for mecillinam and trimethoprim whereas a PEC/PNEC ratio >1 was found for ciprofloxacin.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Avian Pathogenic Isolated in Poultry Farms in Bangladesh that Use Antibiotics Extensively.
Microb Drug Resist
November 2024
Agribio, Agriculture Victoria Research, Bundoora, Australia.
Colibacillosis caused by avian pathogenic (APEC) is causing economic losses to the global poultry industry. Increased prevalence of antibiotic resistance in APEC is the leading cause for increased indiscriminate use of various antimicrobial compounds in farms. The study aimed to investigate the presence of phenotypic and genotypic markers for antibiotic resistance, metals, and biocides in APEC from Bangladeshi poultry and details about the antimicrobials used in poultry farms.
View Article and Find Full Text PDFActivity of mecillinam against USA urinary tract clinical isolates from 2017 to 2020 including isolates resistant to comparator antibiotics.
J Glob Antimicrob Resist
December 2024
Maxel Consulting ApS, Jyllinge, Denmark.
Article Synopsis
- A study was conducted to investigate the effectiveness of mecillinam and pivmecillinam against urinary tract infection (UTI) bacteria in the U.S. from 2017 to 2020, highlighting its potential as a treatment option.
- Mecillinam showed high susceptibility rates (94.9%) among UTI-causing Enterobacterales, especially against extended-spectrum beta-lactamase (ESBL)-positive strains (98.2%).
- The findings support the clinical development of mecillinam as a promising first-line therapy for uncomplicated UTIs, especially when other common antibiotics showed higher resistance rates.
Safety, pharmacokinetics, and food-effect of pivmecillinam after single- and multiple-dose in healthy Chinese subjects: a phase I study.
Naunyn Schmiedebergs Arch Pharmacol
October 2024
School of Pharmacy, Nanjing Medical University, Nanjing, 211166, China.
Urinary tract infection (UTI) is one of the most prevalent bacterial infectious diseases worldwide. However, the resistance of urinary pathogens to other UTI antibiotics such as trimethoprim and trimethoprim/sulphamethoxazole increased. Pivmecillinam is a prodrug of mecillinam, which is effective for the treatment of urinary tract infections.
View Article and Find Full Text PDFInteractions of plumbagin with five common antibiotics against Staphylococcus aureus in vitro.
PLoS One
January 2024
College of Pharmaceutical Engineering of Traditional Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Staphylococcus aureus is the main culprit, causing a variety of severe clinical infections. At the same time, clinics are also facing the severe situation of antibiotic resistance. Therefore, effective strategies to address this problem may include expanding the antimicrobial spectrum by exploring alternative sources of drugs or delaying the development of antibiotic resistance through combination therapy so that existing antibiotics can continue to be used.
View Article and Find Full Text PDFThe Percentage of Antibiotic Resistance in Uncomplicated Community-Acquired Urinary Tract Infections.
Dtsch Arztebl Int
March 2024
Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin; Department 1: Healthcare Research, Institute for Public Health and Nursing Research, University of Bremen; Institute for General Medicine, University Hospital Würzburg.
Background: Uncomplicated bacterial urinary tract infections(uUTIs) are commonly seen in outpatient practice. They are usuallytreated empirically with antibiotics. The pertinent German ClinicalPractice Guideline contains recommendations on antibiotic selection,with the additional advice that the local resistance situationshould be considered as well.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!